Acute promyelocytic leukaemia (APL) represents a unique and once highly fatal subtype of acute myeloid leukaemia that is now considered among the most curable forms of haematological malignancies.

Early studies indicate oral arsenic trioxide provides similar systemic exposure to IV dosing. The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation ...

Findings from the international study involving about 220 newly diagnosed and relapse patient samples pave the way for development of new therapies A study led by a team of scientists from the Cancer ...

Misuse of Pirated Drugs: Why China? What Is Next? Fig 1 The median costs of intravenous arsenic trioxide (ATO) or oral arsenic (the Realgar-Indigo naturalis formula [RIF]) per day in China and other ...

APOLLO: Optimizing the Treatment of High-Risk Acute Promyelocytic Leukemia With All-Trans Retinoic Acid and Arsenic Trioxide While Minimizing the Role of Chemotherapy The following represents ...

Researchers at Zhejiang University School of Medicine have identified a single point mutation in the normal PML gene that can block the effect of arsenic trioxide, a frontline drug for acute ...

Jaguars player Josh Hines-Allen's 8-year-old son, Wesley, served as an honorary captain for the team's game against Seattle. Wesley was diagnosed with Acute Promyelocytic Leukemia in January but is ...

CHICAGO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Quetzal Therapeutics , a biopharmaceutical company specializing in developing transformative treatments for rare diseases, announced the initiation of a ...

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology ...

Medications for AML include chemotherapy and newer targeted therapies. With several options available, the right medication for you will depend on the specific characteristics of your cancer. Acute ...